Emphasis

A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines (EMPHASIS-HF)

Stadium: klaar
Middel: inspra (eplerenone)
Populatie: Hartfalen
Fase: III
First Patient In: 1 januari 2005
Last Patient In: -
Last Patient Last Visit: -

Studiedirecteur

dr. P.H.J.M. Dunselman †

Cardioloog